Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 85, Issue 2, 2014, Pages 159-164

  Vriend, Chris ^a,b   Raijmakers, Pieter ^a   Veltman, Dick J ^a,b   Van Dijk, Karin D ^a,b   Van Der Werf, Ysbrand D ^a,b   Foncke, Elisabeth M J ^a   Smit, Jan H ^a   Berendse, Henk W ^a,b   Van Den Heuvel, Odile A ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER; IODINE 123; LEVODOPA; N OMEGA FLUOROPROPYL 2BETA CARBOMETHOXY 3BETA (4 IODOPHENY)NORTROPANE I 123; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CAUDATE NUCLEUS; CORPUS STRIATUM; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE SEVERITY; DOPAMINERGIC DEFICIT; DOPAMINERGIC SYSTEM; DRUG PROTEIN BINDING; FEMALE; GAMMA CAMERA; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; RETROSPECTIVE STUDY; RIGHT HEMISPHERE; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOM;

DEPRESSION; PARKINSON'S DISEASE; SPECT;

AGED; CAUDATE NUCLEUS; CROSS-SECTIONAL STUDIES; DEPRESSION; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PARKINSON DISEASE; PUTAMEN; RETROSPECTIVE STUDIES; TROPANES;

EID: 84893486418     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-304811     Document Type: Article

References (39)

1. Aarsland D, Pahlhagen S, Ballard CG, et al. Depression in Parkinson disease-epidemiology, mechanisms and management. Nat Rev Neurol. 2012;8:35-47.
2. Rickards H. Depression in neurological disorders: Parkinson's disease, multiple sclerosis, and stroke. J Neurol Neurosurg Psychiatry 2005;76(Suppl 1):i48-52. (Pubitemid 40293043)
3. Hawkes CH. The prodromal phase of sporadic Parkinson's disease: does it exist and if so how long is it? Mov Disord 2008;23:1799-807.
4. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 1988;318:876-80. (Pubitemid 18090271)
5. Hesse S, Meyer PM, Strecker K, et al. Monoamine transporter availability in Parkinson's disease patients with or without depression. Eur J Nucl Med Mol Imaging 2009;36:428-35.
6. Rektorova I, Srovnalova H, Kubikova R, et al. Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson's disease. Mov Disord 2008;23:1580-7.
7. Remy P, Doder M, Lees A, et al. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005;128 (Pt 6):1314-22. (Pubitemid 40826185)
8. Weintraub D, Newberg AB, Cary MS, et al. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease. J Nucl Med 2005;46:227-32. (Pubitemid 43073428)
9. Broussolle E, Dentresangle C, Landais P, et al. The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease. J Neurol Sci 1999;166:141-51. (Pubitemid 29339086)
10. Felicio AC, Moriyama TS, Godeiro-Junior C, et al. Higher dopamine transporter density in Parkinson's disease patients with depression. Psychopharmacology (Berl) 2010;211:27-31.
11. Frisina PG, Haroutunian V, Libow LS. The neuropathological basis for depression in Parkinson's disease. Parkinsonism Relat Disord 2009;15:144-8.
12. Politis M, Wu K, Loane C, et al. Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts. Sci Transl Med 2012;4:128ra41.
13. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986;9:357-81. (Pubitemid 16055790)
14. Groenewegen HJ, Uylings HBM. Organization of prefrontal-striatal connections. In: Steiner H, Tseng KY. eds. Handbook of basal ganglia structure and function. San Diego, CA: Academic Press, 2010:353-65.
15. Haber SN, Calzavara R. The cortico-basal ganglia integrative network: the role of the thalamus. Brain Res Bull. 2009;78:69-74.
16. Leh SE, Ptito A, Chakravarty MM, et al. Fronto-striatal connections in the human brain: a probabilistic diffusion tractography study. Neurosci Lett 2007;419:113-18. (Pubitemid 46719662)
17. Daniel SE, Lees AJ. Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl 1993;39:165-72. (Pubitemid 23216938)
18. Booij J, Kemp P. Dopamine transporter imaging with [(123)I]FP-CIT SPECT: potential effects of drugs. Eur J Nucl Med Mol Imaging 2008;35:424-38.
19. Olde Dubbelink KT, Stoffers D, Deijen JB, et al. Cognitive decline in Parkinson's disease is associated with slowing of resting-state brain activity: a longitudinal study. Neurobiol Aging 2013;34:408-18.
20. Lavalaye J, Booij J, Reneman L, et al. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers. Eur J Nucl Med 2000;27:867-9. (Pubitemid 30456771)
21. Cubo E, Martin PM, Martin-Gonzalez JA, et al. Motor laterality asymmetry and nonmotor symptoms in Parkinson's disease. Mov Disord 2010;25:70-5.
22. Grimm S, Beck J, Schuepbach D, et al. Imbalance between left and right dorsolateral prefrontal cortex in major depression is linked to negative emotional judgment: an fMRI study in severe major depressive disorder. Biol Psychiatry 2008;63:369-76.
23. Gabbay V, Hess DA, Liu S, et al. Lateralized caudate metabolic abnormalities in adolescent major depressive disorder: a proton MR spectroscopy study. Am J Psychiatry 2007;164:1881-9. (Pubitemid 351739242)
24. Pirker W. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it? Mov Disord 2003;18(Suppl 7):S43-51. (Pubitemid 37336928)
25. Eshuis SA, Maguire RP, Leenders KL, et al. Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease. Eur J Nucl Med Mol Imaging 2006;33:200-9. (Pubitemid 43152888)
26. Benamer HT, Patterson J, Wyper DJ, et al. Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake. Mov Disord 2000;15:692-8. (Pubitemid 30479622)
27. Koolschijn PC, van Haren NE, Lensvelt-Mulders GJ, et al. Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum Brain Mapp 2009;30:3719-35.
28. Price JL, Drevets WC. Neural circuits underlying the pathophysiology of mood disorders. Trends Cogn Sci 2012;16:61-71.
29. Pizzagalli DA, Holmes AJ, Dillon DG, et al. Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am J Psychiatry 2009;166:702-10.
30. Mayberg HS, Starkstein SE, Sadzot B, et al. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Ann Neurol 1990;28:57-64. (Pubitemid 20222152)
31. Feldmann A, Illes Z, Kosztolanyi P, et al. Morphometric changes of gray matter in Parkinson's disease with depression: a voxel-based morphometry study. Mov Disord 2008;23:42-6. (Pubitemid 351281216)
32. Kostic VS, Agosta F, Petrovic I, et al. Regional patterns of brain tissue loss associated with depression in Parkinson disease. Neurology 2010;75:857-63.
33. Groenewegen HJ, Trimble M. The ventral striatum as an interface between the limbic and motor systems. CNS Spectr 2007;12:887-92.
34. Pioli EY, Meissner W, Sohr R, et al. Differential behavioral effects of partial bilateral lesions of ventral tegmental area or substantia nigra pars compacta in rats. Neuroscience 2008;153:1213-24.
35. Friedman A, Friedman Y, Dremencov E, et al. VTA dopamine neuron bursting is altered in an animal model of depression and corrected by desipramine. J Mol Neurosci 2008;34:201-9.
36. West CH, Weiss JM. Effects of chronic antidepressant drug administration and electroconvulsive shock on activity of dopaminergic neurons in the ventral tegmentum. Int J Neuropsychopharmacol 2011;14:201-10.
37. Williams JR, Hirsch ES, Anderson K, et al. A comparison of nine scales to detect depression in Parkinson disease: which scale to use? Neurology 2012;78:998-1006.
38. Seppi K, Weintraub D, Coelho M, et al. The Movement Disorder Society Evidence-Based Medicine Review Update: treatments for the non-motor symptoms of Parkinson's disease. Mov Disord 2011;26(Suppl 3):S42-80.
39. Maricle RA, Nutt JG, Valentine RJ, et al. Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: a double-blind, placebo-controlled study. Neurology 1995;45:1757-60.